MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Encompass Health Stock

Encompass Health Corporation

EHCNYSEMarkt
US$127.87
+0.1% today

Company data

Sector
Healthcare
Industry
Medical - Care Facilities
Country
United States
CEO
Mark J. Tarr
Employees
29,699
Market cap
$12.6 B
IPO
24/09/1986

Encompass Health Corporation provides a variety of post-acute healthcare services across the United States, delivered both in dedicated facilities and directly within patients' homes. The company operates through two primary divisions. The Inpatient Rehabilitation division specializes in providing focused recovery…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Encompass Health stock: price history

16/10/25+4 %16/10/26

1D

+0.1%

1W

+3.7%

1M

+3.2%

6M

+20.2%

YTD

+20.5%

1Y

+4.0%

2Y

+31.3%

5Y

+137.9%

10Y

+299.7%

Next earnings date

Next earnings date

28/10/2026 (in 11 days)

Volatility around earnings

~26% stronger price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 14/10/26. Not a buy or sell signal.Beta

What does this mean?

Volatility squeeze

Bullish

Price swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Ask the agents about Encompass Health

Analyst assessment of Encompass Health

PRICE TARGET LOW

US$144.00

CONSENSUS

US$150.20

MEDIAN

US$150.00

PRICE TARGET HIGH

US$155.00

1

STRONG BUY

21

BUY

4

HOLD

1

SELL

0

STRONG SELL

27

TOTAL · Buy

As of: 10/08/2026

ANALYST FIRMRATINGACTIONDATE
TD CowenBuymaintain10/08/2026
UBSBuymaintain07/08/2026
Truist SecuritiesBuymaintain07/08/2026
BarclaysOverweightmaintain06/08/2026
BarclaysOverweightmaintain05/05/2026
BarclaysOverweightmaintain06/02/2026
BarclaysOverweightmaintain30/10/2025
UBSBuymaintain02/10/2025 (older than 12 months)

Encompass Health stock metrics

P/E

20.56

P/B

4.86

EV/EBITDA

10.23

RETURN ON EQUITY

5.9%

NET MARGIN

9.6%

DEBT/EQUITY

1.09

DIVIDEND YIELD

0.6%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

99.0%

FLOAT SHARES

97,652,660

AVG. DAILY VOLUME (30D)

909,826

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Price Andrew L

OfficerSale5,211120.93Spontaneous01/09/2026

Darby John Patrick

OfficerSale4,858121.09Spontaneous01/09/2026

Darby John Patrick

OfficerOption exercise4,85835.06Spontaneous01/09/2026

COLTHARP DOUGLAS E

OfficerSale18,869125.38Spontaneous11/08/2026

Tarr Mark J

OfficerSale1,579126.06Spontaneous11/08/2026
Page 1 / 7

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Copeland Capital Management, LLC713,677-141,73830/09/2026
REINHART PARTNERS, INC.404,257-31,10530/09/2026
CONGRESS ASSET MANAGEMENT CO /MA396,336-9,78530/09/2026
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/281,075+46,51230/09/2026
Sivik Global Healthcare LLC40,000+25,00030/09/2026
Page 1 / 3

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
01/10/202615/10/2026US$0.210.7 %
01/07/202615/07/2026US$0.190.7 %
01/04/202615/04/2026US$0.190.8 %
02/01/202615/01/2026US$0.190.7 %
01/10/202515/10/2025US$0.190.6 %
Page 1 / 8

Stock splits

DATERATIO
01/07/20221257:1000
26/10/20061:5
18/03/19972:1
18/04/19952:1
02/01/19923:2

Comparable stocks

Frequently asked questions about Encompass Health stock

What does Encompass Health do?

Encompass Health Corporation is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.

The CEO is Mark J. Tarr, the company employs around 29,699 people.

The IPO was on 24/09/1986; the stock trades on NYSE under the ticker EHC.

What do analysts say about Encompass Health stock?

27 analysts rate the stock, the consensus is Buy (as of 10/08/2026).

The average price target is US$150.20, ranging from US$144.00 to US$155.00, with a median of US$150.00.

This is an external assessment, not a statement by Market Jury.

When does Encompass Health report next?

The next earnings date is 28/10/2026.

Around past earnings, price swings were roughly 26% stronger than usual.

Does Encompass Health pay a dividend?

Yes. The last dividend was US$0.21 per share, ex-date 01/10/2026, paid on 15/10/2026.

The dividend yield is 0.6% (as of 30/06/2026).

Which stocks are comparable to Encompass Health?

Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.

How can I get Encompass Health stock analyzed?

Clicking "Analyze stock" lets five strategies assess Encompass Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.